Literature DB >> 8254702

Fluoxetine: adverse effects and drug-drug interactions.

F S Messiha1.   

Abstract

This overview summarizes the major and minor side effects and drug interactions of fluoxetine. The adverse reactions include the "serotonin syndrome", cardiovascular complications, extrapyramidal side effects such as akathisia, dyskinesias, and parkinsonian-like syndromes and an apparently increased risk of suicidality. Fluoxetine-induced mania and hypomania, seizures and sexual disorders are evaluated along with minor symptoms of allergic reactions, stuttering, hematological changes, psoriasis, and inappropriate secretion of the antidiuretic hormone. The major fluoxetine-drug interactions involve the amino acids L-dopa and L-tryptophan, anorexiants, anticonvulsants, antidepressants, anxiolytics, calcium channel blockers, cyproheptadine, lithium salts, and drugs of abuse. The underlying mechanism and the paradoxical effects of fluoxetine are addressed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8254702     DOI: 10.3109/15563659309025765

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  8 in total

1.  Fluoxetine interacts with the lipid bilayer of the inner membrane in isolated rat brain mitochondria, inhibiting electron transport and F1F0-ATPase activity.

Authors:  C Curti; F E Mingatto; A C Polizello; L O Galastri; S A Uyemura; A C Santos
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

2.  Fluoxetine-induced pill oesophagitis.

Authors:  Abdul Majid Wani; Abdul Gaffar Shiekh; Waleed M Hussain; Wail Al Miamini; Amer M Khoujah; Najah R Zayyani
Journal:  BMJ Case Rep       Date:  2011-06-30

3.  Modulation of 5-HT4 receptor function in the rat isolated ileum by fluoxetine: the involvement of endogenous 5-hydroxytryptamine.

Authors:  B R Tuladhar; B Costall; R J Naylor
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

4.  Clozapine-induced stuttering: an estimate of prevalence in the west of Ireland.

Authors:  Ruth Murphy; Anne Gallagher; Kapil Sharma; Tariq Ali; Elizabeth Lewis; Ivan Murray; Brian Hallahan
Journal:  Ther Adv Psychopharmacol       Date:  2015-08

Review 5.  Safety of selegiline (deprenyl) in the treatment of Parkinson's disease.

Authors:  E H Heinonen; V Myllylä
Journal:  Drug Saf       Date:  1998-07       Impact factor: 5.606

Review 6.  Tolerability and safety of fluvoxamine and other antidepressants.

Authors:  H G M Westenberg; C Sandner
Journal:  Int J Clin Pract       Date:  2006-04       Impact factor: 2.503

7.  Localization of the Serotonin Transporter in the Dog Intestine and Comparison to the Rat and Human Intestines.

Authors:  Roberto Chiocchetti; Giorgia Galiazzo; Fiorella Giancola; Claudio Tagliavia; Chiara Bernardini; Monica Forni; Marco Pietra
Journal:  Front Vet Sci       Date:  2022-01-05

Review 8.  Neurogenic Stuttering: Etiology, Symptomatology, and Treatment.

Authors:  Lejla Junuzovic-Zunic; Osman Sinanovic; Blazenka Majic
Journal:  Med Arch       Date:  2021-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.